Shannon T. Kelley's most recent trade in Madrigal Pharmaceuticals Inc was a trade of 458 Common Stock done at an average price of $358.7 . Disclosure was reported to the exchange on Aug. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Madrigal Pharmaceuticals Inc | Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 358.66 per share. | 18 Aug 2025 | 458 | 10,019 (0%) | 0% | 358.7 | 164,266 | Common Stock |
| Madrigal Pharmaceuticals Inc | Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 372.44 per share. | 18 Aug 2025 | 252 | 9,473 (0%) | 0% | 372.4 | 93,855 | Common Stock |
| Madrigal Pharmaceuticals Inc | Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 375.75 per share. | 18 Aug 2025 | 190 | 9,215 (0%) | 0% | 375.8 | 71,393 | Common Stock |
| Madrigal Pharmaceuticals Inc | Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 369.64 per share. | 18 Aug 2025 | 126 | 9,893 (0%) | 0% | 369.6 | 46,575 | Common Stock |
| Madrigal Pharmaceuticals Inc | Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 371.35 per share. | 18 Aug 2025 | 84 | 9,725 (0%) | 0% | 371.3 | 31,193 | Common Stock |
| Madrigal Pharmaceuticals Inc | Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 370.06 per share. | 18 Aug 2025 | 84 | 9,809 (0%) | 0% | 370.1 | 31,085 | Common Stock |
| Madrigal Pharmaceuticals Inc | Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 374.13 per share. | 18 Aug 2025 | 68 | 9,405 (0%) | 0% | 374.1 | 25,441 | Common Stock |
| Madrigal Pharmaceuticals Inc | Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 376.62 per share. | 18 Aug 2025 | 42 | 9,173 (0%) | 0% | 376.6 | 15,818 | Common Stock |
| Madrigal Pharmaceuticals Inc | Shannon T. Kelley | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 5,368 | 5,368 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharmaceuticals Inc | Shannon T. Kelley | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 3,187 | 10,477 (0%) | 0% | 0 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 335.00 per share. | 03 Mar 2025 | 415 | 7,290 (0%) | 0% | 335 | 139,025 | Common Stock |
| Madrigal Pharmaceuticals Inc | Shannon T. Kelley | General Counsel | Sale of securities on an exchange or to another person at price $ 273.41 per share. | 17 Jan 2025 | 277 | 7,705 (0%) | 0% | 273.4 | 75,735 | Common Stock |
| Madrigal Pharmaceuticals Inc | Shannon T. Kelley | General Counsel | 15 Aug 2024 | 7,820 | 7,820 | - | - | Stock Option (Right to Buy) | ||
| Madrigal Pharmaceuticals Inc | Shannon T. Kelley | General Counsel | 15 Aug 2024 | 5,215 | 7,982 (0%) | 0% | 0 | Common Stock |